STENTRODE First in Human Early Feasibility Study

About this trial

This is a first in human trial in five individuals, to evaluate the safety of a device to record brain activity without open brain surgery. Additionally, the trial will evaluate the ability of the device to transmit brain signals for one year after implantation. Although not the purpose of this trial, devices such as these may be used to control assistive technology that can perform activities for individuals who are unable to use their arms. If included in this trial, the Stentrode™ device, a small metallic mesh tube with electrode contacts, will be placed into a blood vessel of the brain. Participants will be monitored for adverse events over 12 months. There is no control group in this study.